Press Releases

general insights

Source

Novavax

Published

March 11, 2021

contact us hero image

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain..

6 min read

faberco general insights

Source

Philstar Global

Published

March 09, 2021

galvez

National Task Force Against COVID-19 chief implementer Carlito Galvez Jr. is set to fly to India today to sign vaccine supply agreements with Novavax and the Serum Institute of India (SII)...

3 min read

faberco press release

Faberco Life Sciences, Inc, in partnership with Serum Institute of India (SII) is making CovovaxTM, the COVID-19 vaccine developed by Novavax available in the Philippines...

3 min read

general insights

Source

GMA News Online

Published

January 10, 2020

covovax galvez

Serum Institute of India (SII) over the weekend announced that the Philippine government—through vaccine czar Carlito Galvez Jr.—has inked a term sheet to secure some 30 million doses of the coronavirus disease 2019 (COVID-19) vaccine Covovax set to arrive in the country by the third quarter of 2021...

3 min read

faberco generral insights

Source

TheStar

Published

November 20, 2020

dian firm vows access to vaccine

INDIAN pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has committed to making the Covid-19 vaccine available to the Philippines once it is developed...

3 min read

faberco general insights

Source

Inquirer.net

Published

November 18, 2020

indian vaccine makers vows

MANILA, Philippines — Indian pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has committed to making available the vaccine against the coronavirus in the Philippines once it is developed...

5 min read

general insights faberco

Source

GMA News Online

Published

November 18, 2020

general insights faberco

The Serum Institute of India has authorized Faberco Life Sciences, Inc. as the company’s representative in the Philippines in the supply of COVID-19 vaccine it is developing with US biotech Novovax...

3 min read

general insights faberco

Source

BusinessWorld

Published

November 18, 2020

general insights faberco

THE HEALTH department asked President Rodrigo R. Duterte on Tuesday night to issue an order that will fast-track the approval process for coronavirus vaccines...

6 min read

general insights faberco

Published

November 11, 2020

general insights faberco

Molnupiravir, the first oral anti-viral drug clinically proven to reduce the risk of hospitalization or death from known SARS-CoV-2 variants by half...

4 min read

general insights faberco

Published

November 11, 2020

general insights faberco

The Philippines will soon have access to Molnupiravir, an antiviral pill to treat patients who are infected with COVID-19...

5 min read
Quick Connect